Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyll-1,2,3,6-tetrahydropyridine primate model of parkinsonism

Journal of Neuroscience

Volumn 22, Issue 18, 2002, Pages 7850-7855

  Heimer, Gali ^a   Bar Gad, Izhar ^a   Goldberg, Joshua A ^a   Bergman, Hagai ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Basal ganglia; Cross correlations; Globus pallidus; L 3,4 dihydroxyphenylalanine; Monkeys; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BROMOCRIPTINE MESILATE; CARBIDOPA PLUS LEVODOPA; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CELL ACTIVITY; CELL SYNCHRONIZATION; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; GLOBUS PALLIDUS; MONKEY; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SUBSTITUTION THERAPY;

EID: 0037107182     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-18-07850.2002     Document Type: Article

References (32)

1. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
2. Bar-Gad I, Ritov Y, Bergman H (2001) Failure in identification of overlapping spikes from multiple neuron activity causes artificial correlations. J Neurosci Methods 107:1-13.
3. Bedard PJ, Di Paolo T, Falardeau P, Boucher R (1986) Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys: Correlation with [3H]spiperone binding. Brain Res 379:294-299.
4. Ben Shaul Y, Bergman H, Ritov Y, Abeles M (2001) Trial to trial variability in either stimulus or action causes apparent correlation and synchrony in neuronal activity. J Neurosci Methods 111:99-110.
5. Bergman H, Wichmann T, Karmon B, DeLong MR (1994) The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72:507-520.
6. i) in the MPTP-treated monkey. Brain Res 787:157-160.
7. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550.
8. Contreras CM, Mexicano G, Guzman-Flores CA (1981) Stereotaxic brain atlas of the green monkey (Cercopithecus aethiops aethiops). Bol Estud Med Biol 31:383-428.
9. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
10. Filion M, Tremblay L (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547:142-151.
11. Filion M, Tremblay L, Bedard PJ (1991) Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547:152-161.
12. Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC (1996) Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47:219-224.
13. Hurtado JM, Gray CM, Tamas LB, Sigvardt KA (1999) Dynamics of tremor-related oscillations in the human globus pallidus: A single case study. Proc Natl Acad Sci USA 96:1674-1679.
14. Hutchison WD, Lozano AM, Davis KD, Saint Cyr JA, Lang AE, Dostrovsky JO (1994) Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients. NeuroReport 5:1533-1537.
15. Hutchinson WD, Levy R, Dostrovsky JO, Lozano AM, Lang AE (1997) Effects of apomorphine on globus pallidus neurons in parkinsonian patients. Ann Neurol 42:767-775.
16. Imbert C, Bezard E, Guitraud S, Boraud T, Gross CE (2000) Comparison of eight clinical rating scales used for the assessment of MPTP induced parkinsonism in the macaque monkey. J Neurosci Methods 96:71-76.
17. Levy R, Hutchison WD, Lozano AM, Dostrovsky JO (2000) High frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci 20:7766-7775.
18. Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano AM (2001) Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease. J Neurophysiol 86:249-260.
19. Levy R, Hutchison WD, Lozano AM, Dostrovsky JO (2002) Synchronized neuronal discharge in the basal ganglia of parkinsonian patients is limited to oscillatory activity. J Neurosci 22:2855-2861.
20. i spontaneous outflow in patients with Parkinson's disease. Mov Disord 14:45-49.
21. Miller WC, DeLong MR (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: The Basal Ganglia II (Carpenter MB, Jayaraman A, eds), pp 415-427. New York: Plenum.
22. Mitchell IJ, Boyce S, Sambrook MA, Crossman AR (1992) A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain: Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. Brain 115:809-824.
23. Nini A, Feingold A, Slovin H, Bergman H (1995) Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophysiol 74:1800-1805.
24. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW (2000) Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23:S8-S19.
25. Papa SM, DeSimone R, Fiorani M, Oldfield EH (1999) Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann Neurol 46:732-738.
26. Pearce RK, Jackson M, Smith L, Jenner P, Marsden CD (1995) Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus). Mov Disord 10:731-740.
27. Raz A, Vaadia E, Bergman H (2000) Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 20:8559-8571.
28. Vidailhet M, Bonnet AM, Marconi R, Durif F, Agid Y (1999) The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease. Mov Disord 14 [Suppl 1]:13-18.
29. Vila M, Levy R, Herrero MT, Ruberg M, Faucheux B, Obeso JA, Agid Y, Hirsch EC (1997) Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: An in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 17:765-773.
30. Walters JR, Ruskin DN, Allers KA, Bergstrom DA (2000) Pre- and postsynaptic aspects of dopamine-mediated transmission. Trends Neurosci 23:S41-S47.
31. Wichmann T, Bergman H, Starr PA, Subramanian T, Watts RL, DeLong MR (1999) Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res 125:397-409.
32. Wichmann T, Kliem MA, Soares JC (2002) Slow oscillatory discharge in the primate basal ganglia. J Neurophysiol 87:1145-1148.